• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性脑海绵状血管畸形患者的病灶中CCM基因存在体细胞突变:CCM发病机制的共同生化途径的证据

Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.

作者信息

McDonald David A, Shi Changbin, Shenkar Robert, Gallione Carol J, Akers Amy L, Li Stephanie, De Castro Nicholas, Berg Michel J, Corcoran David L, Awad Issam A, Marchuk Douglas A

机构信息

Molecular Genetics and Microbiology Department, Duke University Medical Center, Durham, NC 27710, USA.

Section of Neurosurgery, Biological Sciences Division, University of Chicago, Chicago, IL 60637, USA.

出版信息

Hum Mol Genet. 2014 Aug 15;23(16):4357-70. doi: 10.1093/hmg/ddu153. Epub 2014 Apr 3.

DOI:10.1093/hmg/ddu153
PMID:24698976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4103679/
Abstract

Cerebral cavernous malformations (CCMs) are vascular lesions affecting the central nervous system. CCM occurs either sporadically or in an inherited, autosomal dominant manner. Constitutional (germline) mutations in any of three genes, KRIT1, CCM2 and PDCD10, can cause the inherited form. Analysis of CCM lesions from inherited cases revealed biallelic somatic mutations, indicating that CCM follows a Knudsonian two-hit mutation mechanism. It is still unknown, however, if the sporadic cases of CCM also follow this genetic mechanism. We extracted DNA from 11 surgically excised lesions from sporadic CCM patients, and sequenced the three CCM genes in each specimen using a next-generation sequencing approach. Four sporadic CCM lesion samples (36%) were found to contain novel somatic mutations. Three of the lesions contained a single somatic mutation, and one lesion contained two biallelic somatic mutations. Herein, we also describe evidence of somatic mosaicism in a patient presenting with over 130 CCM lesions localized to one hemisphere of the brain. Finally, in a lesion regrowth sample, we found that the regrown CCM lesion contained the same somatic mutation as the original lesion. Together, these data bolster the idea that all forms of CCM have a genetic underpinning of the two-hit mutation mechanism in the known CCM genes. Recent studies have found aberrant Rho kinase activation in inherited CCM pathogenesis, and we present evidence that this pathway is activated in sporadic CCM patients. These results suggest that all CCM patients, including those with the more common sporadic form, are potentially amenable to the same therapy.

摘要

脑海绵状血管畸形(CCMs)是影响中枢神经系统的血管病变。CCM可散发出现,也可呈常染色体显性遗传方式遗传。KRIT1、CCM2和PDCD10这三个基因中任何一个发生的胚系(种系)突变都可导致遗传形式。对遗传性病例的CCM病变分析显示存在双等位基因体细胞突变,这表明CCM遵循Knudsonian两次打击突变机制。然而,散发性CCM病例是否也遵循这种遗传机制仍不清楚。我们从散发性CCM患者手术切除的11个病变中提取了DNA,并使用下一代测序方法对每个样本中的三个CCM基因进行了测序。发现四个散发性CCM病变样本(36%)含有新的体细胞突变。其中三个病变含有单个体细胞突变,一个病变含有两个双等位基因体细胞突变。在此,我们还描述了一名患者的体细胞镶嵌现象的证据,该患者大脑一侧半球有超过130个CCM病变。最后,在一个病变再生样本中,我们发现再生的CCM病变与原始病变含有相同的体细胞突变。总之,这些数据支持了所有形式的CCM在已知CCM基因中都有两次打击突变机制的遗传基础这一观点。最近的研究发现遗传性CCM发病机制中存在异常的Rho激酶激活,我们提供的证据表明该途径在散发性CCM患者中也被激活。这些结果表明,所有CCM患者,包括那些更常见的散发性形式的患者,都可能适合相同的治疗方法。

相似文献

1
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.散发性脑海绵状血管畸形患者的病灶中CCM基因存在体细胞突变:CCM发病机制的共同生化途径的证据
Hum Mol Genet. 2014 Aug 15;23(16):4357-70. doi: 10.1093/hmg/ddu153. Epub 2014 Apr 3.
2
Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis.脑海绵状血管畸形(CCM)中的双等位基因体细胞和种系突变:CCM发病机制的双打击机制证据
Hum Mol Genet. 2009 Mar 1;18(5):919-30. doi: 10.1093/hmg/ddn430. Epub 2008 Dec 16.
3
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.一种基于双打击突变假说的新型脑动静脉畸形小鼠模型重现了人类疾病。
Hum Mol Genet. 2011 Jan 15;20(2):211-22. doi: 10.1093/hmg/ddq433. Epub 2010 Oct 11.
4
Genomic causes of multiple cerebral cavernous malformations in a Japanese population.日本人多发性脑内海绵状血管畸形的基因组病因。
J Clin Neurosci. 2013 May;20(5):667-9. doi: 10.1016/j.jocn.2012.05.041. Epub 2013 Feb 26.
5
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.与PDCD10突变相关的脑海绵状血管畸形疾病的异常侵袭性。
Genet Med. 2015 Mar;17(3):188-196. doi: 10.1038/gim.2014.97. Epub 2014 Aug 14.
6
Update on Novel CCM Gene Mutations in Patients with Cerebral Cavernous Malformations.脑海绵状血管畸形患者新型CCM基因突变的最新进展
J Mol Neurosci. 2017 Feb;61(2):189-198. doi: 10.1007/s12031-016-0863-z. Epub 2016 Dec 20.
7
Sporadic cerebral cavernous malformations: report of further mutations of CCM genes in 40 Italian patients.散发性脑内海绵状血管畸形:40 例意大利患者 CCM 基因突变的进一步报告。
Biomed Res Int. 2013;2013:459253. doi: 10.1155/2013/459253. Epub 2013 Aug 22.
8
A single-center study on 140 patients with cerebral cavernous malformations: 28 new pathogenic variants and functional characterization of a PDCD10 large deletion.一项针对 140 例脑海绵状血管畸形患者的单中心研究:28 个新的致病性变异和 PDCD10 大片段缺失的功能特征。
Hum Mutat. 2018 Dec;39(12):1885-1900. doi: 10.1002/humu.23629. Epub 2018 Sep 24.
9
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.CCM2 和 CCM3 在脑动静脉畸形中的差异血管生成功能。
Neurosurg Focus. 2010 Sep;29(3):E1. doi: 10.3171/2010.5.FOCUS1090.
10
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.脑海绵状血管畸形:血管内皮细胞中的体细胞突变
Neurosurgery. 2009 Jul;65(1):138-44; discussion 144-5. doi: 10.1227/01.NEU.0000348049.81121.C1.

引用本文的文献

1
Late-onset familial cerebral cavernous malformation without a family history: a case description.无家族病史的迟发性家族性脑海绵状血管畸形:病例描述
Quant Imaging Med Surg. 2025 Sep 1;15(9):8717-8721. doi: 10.21037/qims-2025-760. Epub 2025 Aug 12.
2
Epidemiology and Aetiology of Cerebral Cavernous Malformations.脑海绵状血管畸形的流行病学与病因学
Acta Neurochir Suppl. 2025;136:143-149. doi: 10.1007/978-3-031-89844-0_18.
3
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteins.人血管类器官的高通量分化揭示了脑海绵状血管畸形蛋白的重叠和独特功能。
Angiogenesis. 2025 Jun 6;28(3):32. doi: 10.1007/s10456-025-09985-5.
4
Genetic Insights Into Hemorrhagic Stroke and Vascular Malformations: Pathogenesis and Emerging Therapeutic Strategies.出血性中风和血管畸形的遗传学见解:发病机制与新兴治疗策略
Stroke. 2025 May;56(5):1298-1311. doi: 10.1161/STROKEAHA.124.045182. Epub 2025 Mar 14.
5
Cerebral Cavernous Malformation: From Genetics to Pharmacotherapy.脑海绵状血管畸形:从遗传学至药物治疗
Brain Behav. 2025 Jan;15(1):e70223. doi: 10.1002/brb3.70223.
6
Cerebral vascular malformations: pathogenesis and therapy.脑血管畸形:发病机制与治疗
MedComm (2020). 2024 Dec 8;5(12):e70027. doi: 10.1002/mco2.70027. eCollection 2024 Dec.
7
Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.遗传性出血性毛细血管扩张症动静脉畸形中的体细胞突变支持发病机制的双等位基因两次打击突变机制。
Am J Hum Genet. 2024 Oct 3;111(10):2283-2298. doi: 10.1016/j.ajhg.2024.08.020. Epub 2024 Sep 18.
8
Bringing CCM into a dish: cell culture models for cerebral cavernous malformations.将大脑海绵状血管畸形研究引入培养皿:大脑海绵状血管畸形的细胞培养模型
Med Genet. 2021 Dec 3;33(3):251-259. doi: 10.1515/medgen-2021-2091. eCollection 2021 Sep.
9
Transcriptomic signatures of individual cell types in cerebral cavernous malformation.脑动静脉畸形中单个细胞类型的转录组特征。
Cell Commun Signal. 2024 Jan 9;22(1):23. doi: 10.1186/s12964-023-01301-2.
10
mTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.mTORC1 抑制剂雷帕霉素抑制成年小鼠脑内海绵状血管畸形的生长。
Stroke. 2023 Nov;54(11):2906-2917. doi: 10.1161/STROKEAHA.123.044108. Epub 2023 Sep 25.

本文引用的文献

1
Somatic uniparental isodisomy explains multifocality of glomuvenous malformations.体单亲源同二倍体解释了丛状静脉畸形的多灶性。
Am J Hum Genet. 2013 Feb 7;92(2):188-96. doi: 10.1016/j.ajhg.2012.12.017. Epub 2013 Jan 31.
2
Phasic contractions of isolated human myometrium are associated with Rho-kinase (ROCK)-dependent phosphorylation of myosin phosphatase-targeting subunit (MYPT1).分离的人子宫平滑肌的时相收缩与 Rho 激酶 (ROCK) 依赖性肌球蛋白磷酸酶靶向亚单位 (MYPT1) 的磷酸化有关。
Mol Hum Reprod. 2012 May;18(5):265-79. doi: 10.1093/molehr/gar078. Epub 2011 Dec 8.
3
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.法舒地尔可减少脑动静脉畸形疾病小鼠模型的病灶负担。
Stroke. 2012 Feb;43(2):571-4. doi: 10.1161/STROKEAHA.111.625467. Epub 2011 Oct 27.
4
The myosin phosphatase targeting protein (MYPT) family: a regulated mechanism for achieving substrate specificity of the catalytic subunit of protein phosphatase type 1δ.肌球蛋白磷酸酶靶向蛋白(MYPT)家族:实现蛋白磷酸酶 1δ 催化亚基底物特异性的调节机制。
Arch Biochem Biophys. 2011 Jun 15;510(2):147-59. doi: 10.1016/j.abb.2011.01.018. Epub 2011 Feb 1.
5
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.一种基于双打击突变假说的新型脑动静脉畸形小鼠模型重现了人类疾病。
Hum Mol Genet. 2011 Jan 15;20(2):211-22. doi: 10.1093/hmg/ddq433. Epub 2010 Oct 11.
6
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.脑内海绵状血管畸形蛋白抑制 Rho 激酶以稳定血管完整性。
J Exp Med. 2010 Apr 12;207(4):881-96. doi: 10.1084/jem.20091258. Epub 2010 Mar 22.
7
Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.Rho 激酶抑制可挽救血管内皮细胞脑海绵状畸形表型。
J Biol Chem. 2010 Apr 16;285(16):11760-4. doi: 10.1074/jbc.C109.097220. Epub 2010 Feb 24.
8
The putative role of the venous system in the genesis of vascular malformations.静脉系统在血管畸形发生中的假定作用。
Neurosurg Focus. 2009 Nov;27(5):E9. doi: 10.3171/2009.8.FOCUS09161.
9
Cerebral cavernous malformations: somatic mutations in vascular endothelial cells.脑海绵状血管畸形:血管内皮细胞中的体细胞突变
Neurosurgery. 2009 Jul;65(1):138-44; discussion 144-5. doi: 10.1227/01.NEU.0000348049.81121.C1.
10
Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells.脑海绵状血管畸形2蛋白在内皮细胞中促进Smad泛素调节因子1介导的RhoA降解。
J Biol Chem. 2009 May 15;284(20):13301-13305. doi: 10.1074/jbc.C900009200. Epub 2009 Mar 24.